Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02648633
Recruitment Status : Terminated (The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.)
First Posted : January 7, 2016
Last Update Posted : May 31, 2017
Information provided by (Responsible Party):
Benjamin Purow, MD, University of Virginia

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 21, 2017
Actual Study Completion Date : February 21, 2017